Correlation Between Aadi Bioscience and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Elevation Oncology, you can compare the effects of market volatilities on Aadi Bioscience and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Elevation Oncology.
Diversification Opportunities for Aadi Bioscience and Elevation Oncology
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aadi and Elevation is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Elevation Oncology go up and down completely randomly.
Pair Corralation between Aadi Bioscience and Elevation Oncology
Given the investment horizon of 90 days Aadi Bioscience is expected to generate 0.53 times more return on investment than Elevation Oncology. However, Aadi Bioscience is 1.89 times less risky than Elevation Oncology. It trades about 0.2 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.08 per unit of risk. If you would invest 177.00 in Aadi Bioscience on September 12, 2024 and sell it today you would earn a total of 65.00 from holding Aadi Bioscience or generate 36.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aadi Bioscience vs. Elevation Oncology
Performance |
| Timeline |
| Aadi Bioscience |
| Elevation Oncology |
Aadi Bioscience and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aadi Bioscience and Elevation Oncology
The main advantage of trading using opposite Aadi Bioscience and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Aadi Bioscience vs. Anebulo Pharmaceuticals | Aadi Bioscience vs. Adagene | Aadi Bioscience vs. Acrivon Therapeutics, Common | Aadi Bioscience vs. AnaptysBio |
| Elevation Oncology vs. Puma Biotechnology | Elevation Oncology vs. Iovance Biotherapeutics | Elevation Oncology vs. Sarepta Therapeutics | Elevation Oncology vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |